Regeneron reports sustained efficacy for FOP treatment Pasatru

🌐 Investing.com (Cyprus) —
Regeneron reports sustained efficacy for FOP treatment Pasatru

AI Summary

Regeneron reported sustained efficacy for Pasatru, a treatment for fibrodysplasia ossificans progressiva (FOP). The article provides no further trial details or data.

Markets Health Regeneron Pasatru FOP treatment efficacy

Read original source →